258 related articles for article (PubMed ID: 8710773)
1. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
[TBL] [Abstract][Full Text] [Related]
2. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
3. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
4. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
[TBL] [Abstract][Full Text] [Related]
5. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
Warner AA; Pettenati MJ; Burton BK
Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
[TBL] [Abstract][Full Text] [Related]
6. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
[TBL] [Abstract][Full Text] [Related]
7. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
Albright SG; Warner AA; Seeds JW; Burton BK
Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
[TBL] [Abstract][Full Text] [Related]
8. Endometrial and fetoplacental markers in pregnancies with fetal congenital nephrosis.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):526-30. PubMed ID: 8693927
[TBL] [Abstract][Full Text] [Related]
9. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
[TBL] [Abstract][Full Text] [Related]
10. AFP and age screening for Down syndrome.
Wald N; Cuckle H
Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
[TBL] [Abstract][Full Text] [Related]
11. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
13. Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
Ryynänen M; Seppälä M; Kuusela P; Rapola J; Aula P; Seppä A; Jokela V; Castren O
Br J Obstet Gynaecol; 1983 May; 90(5):437-42. PubMed ID: 6189511
[TBL] [Abstract][Full Text] [Related]
14. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
Papp Z; Tóth-Pál E; Papp C; Tóth Z; Szabó M; Veress L; Török O
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):320-6. PubMed ID: 8590201
[TBL] [Abstract][Full Text] [Related]
15. [Genetic heterogeneity and pathology of congenital nephrotic syndrome and its significance in prenatal diagnosis].
Braga S; Moser H; Zimmermann A; Oetliker O
J Genet Hum; 1985 Jun; 33(2):153-6. PubMed ID: 2410560
[TBL] [Abstract][Full Text] [Related]
16. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
17. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
[TBL] [Abstract][Full Text] [Related]
18. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
Grau P; Robinson L; Tabsh K; Crandall BF
Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Milunsky A; Alpert E; Neff RK; Frigoletto FD
Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy screening for neural tube defects in Israel.
Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
